Competitor Analysis: Cardiometabolic Peptides

Publisher: La Merie Publishing
Pages: 77
Format: PDF and Online
Product Line:
Competitor Analysis
Product Code: LMCA0004
Release Date: November of 2014

400.00 €
Free of 21 % VAT (except in Spain and also in the European Union without valid intl. VAT no),
Delivery costs do not apply or are included.
You can also order this product via email or fax , please download the Order Form
Need more information?
Ask a question about this product


Competitor Analysis: Cardiometabolic Peptides

The Competitive Intelligence Report Cardiometabolic Peptides as of November 2014 provides a competitor analysis in the development pipeline of peptide therapeutics for treatment of diabetes, obesity and atherosclerosis. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report provides a compilation of currently active projects in research and development for novel cardiometabolic peptides. Competitor projects are listed in a tabular format providing information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Competitor Analysis: Cardiometabolic Peptides

Table of Content:

  • 2013 Sales of Major CardioMetabolic Peptides
  • Selective Peptide GLP-1 Receptor Agonists for CardioMetabolic Diseases
  • Dual Target Peptide GLP-1 Agonists for CardioMetabolic Diseases
  • Other Peptides for Diabetes
  • Other Peptides for Obesity & Lipodystrophy
  • Other Peptides for Diabetes and Obesity & Cardiometabolic Disease
  • Peptides for Atherosclerosis
  • Corporate Cardiometabolic Peptide R&D Pipelines

The above shown price refers to a Single User License. Please contact us for prices of departmental, site or global product licenses.

This Report is NOT a downloadable item but will be delivered via email within 24 h (working days only).

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up